Case Sensitive:Second Chances
|
|
Illustration By Greg Mably
|
Steven Harris, Dennis F. Ramos, on Behalf of
Themselves and All Others Similarly Situated, v. Amgen, Inc.,
Frank J. Biondi, Jr.; Jerry D. Choate; Frank C. Herringer;
Gilbert S. Omenn; Baltimore; Judith C. Pelham; Kevin W.
Sharer; Frederick W. Gluck; Leonard D. Schaeffer; Robert A.
Bradway; Retirement Benefits Committee of the Board of
Directors of Amgen No. 08-55389 (9th U.S. Cir.
2009)
Steven Harris, Dennis F.
Ramos, on Behalf of Themselves and All Others Similarly
Situated, v. Amgen, Inc., Frank J. Biondi, Jr.; Jerry D.
Choate; Frank C. Herringer; Gilbert S. Omenn; Baltimore;
Judith C. Pelham; Kevin W. Sharer; Frederick W. Gluck;
Leonard D. Schaeffer; Robert A. Bradway; Retirement
Benefits Committee of the Board of Directors of Amgen No.
08-55389 (9th U.S. Cir. 2009)
Venue:
9th U.S. Circuit Court of Appeals
The Question:
Does a participant who took a voluntary distribution
still have legal standing to sue for a fiduciary breach
under the Employee Retirement Income and Security Act
(ERISA) despite no longer having a balance in the
employer's defined contribution plan?
The Ruling:
Circuit Judge Ronald M. Gould, writing for the court,
said plaintiff Steve Harris had the right to pursue his
suit against Amgen, a biotech company and Harris's
former employer, despite his voluntary distribution. In
doing so, the 9th Circuit threw out a lower-court decision
from U.S. District Judge Philip S. Gutierrez of the U.S.
District Court for the Central District of California
dismissing the claims by Harris and those of fellow
plaintiff Dennis F. Ramos. Gutierrez ruled Harris had no
legal standing after having taken the distribution and that
both men had not leveled properly drafted breach claims
against anyone considered a legal fiduciary.
The Case:
As in other so-called "stock drop" cases,
in Harris, plaintiffs alleged that biotech company Amgen
continued to keep company stock investments in their
defined contribution plans after the company suffered a
major financial "event" causing its share price
to drop significantly. In this case, there were allegations
of improper off-label drug marketing and sales that Harris
and Ramos charged were directly at fault for the resulting
losses to plan assets with company stock investments.
However, in this case, the two plaintiffs had different
financial postures: Harris had taken a plan distribution in
July 2007 while Ramos' assets remained in an Amgen plan
when the suit was filed in August 2007. That difference in
the plaintiffs' financial postures came into play when
Gutierrez considered Amgen's request to dismiss the case
prior to trial, with the lower court ruling that Harris no
longer had the legal right to pursue his case because of
his prior distribution.
On appeal, Gould reversed the lower court's decision,
holding that even participants who had taken a full
distribution could have standing to bring suit: "When
employees withdraw their funds from a benefit plan, but
claim that they would have had more to withdraw absent
breach of fiduciary duty by those managing the plan, it is
not difficult to see a common sense loss of benefits in
their plan caused by the alleged fiduciary breach. [W]e
hold that employees who cash out of a defined contribution
ERISA plan are still 'participants' in that plan, as
defined by 29 U.S.C. 1002(7), regardless of whether they
withdrew their assets voluntarily. Harris had standing to
complain about his retirement benefits plan."